December 21, 2024 - 04:21

CFRA Research Chief Investment Strategist Sam Stovall recently shared his insights on the market outlook for 2025, expressing a tempered sense of optimism. Following the release of softer-than-expected Personal Consumption Expenditures (PCE) data, Stovall noted that markets are "breathing a sigh of relief." He highlighted several encouraging trends, including a weakening US dollar and rising gold prices, which he believes contribute to a generally positive market environment.
Despite this optimism, Stovall warned of potential volatility in the coming weeks as investors may seek to lock in profits before the new year. Looking further ahead, he projects that the S&P 500 could reach 6,585 by the end of 2025. Stovall characterized his outlook as being "a bull with a lowercase 'b'," reflecting a cautious approach. He emphasized the historical challenges faced by third-year bull markets, citing that only 3 out of 11 have successfully transitioned beyond their second year. As Stovall anticipates market growth, he acknowledges the likely bumps along the road ahead.
September 12, 2026 - 00:50
US Tariff Refunds Slow as Government Collects More Than It Pays OutThe flow of tariff refunds from the US government has slowed sharply, with new figures showing the Treasury took in more money from tariffs than it returned to importers for the first time in...
September 11, 2026 - 02:46
Rayonier Advanced Materials’ (RYAM) Pricing Power Is Surging, But Volumes Tell Another StoryRayonier Advanced Materials reported second-quarter results on August 4 for the period ending June 27, showing a mixed picture of financial performance. Net sales reached $376 million, an 18...
September 10, 2026 - 21:54
OpenAI Rolls Out ChatGPT for Financial Services With Major Industry PartnersOpenAI has introduced a version of ChatGPT built specifically for the financial sector, teaming up with several large brokerages and research organizations, including Morgan Stanley and S&P. The...
September 10, 2026 - 04:58
InMed Reports Full Year Fiscal 2026 Financial Results and Provides Corporate UpdateVancouver-based InMed Pharmaceuticals has released its financial results for the full fiscal year that ended on June 30, 2026, alongside a broader update on its corporate activities. The company,...